Study guide
Postanalytic Reporting
ASCP MLS Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Orientation To ASCP MLS Certification
Credential Purpose And Role ASCP BOC And Eligibility At A High Level MLS Versus MLS(ASCPi) Wording Application Fee And Transcript Result Basics CAT Exam Model Overview Study Plan From Content Guideline
2 Exam Format, CAT Scoring, And Score details
100 Questions And 2h30m Computer Adaptive Testing One-Best-Answer Multiple Choice Theoretical Versus Procedural Questions Scaled Score 100-999, Minimum 400 Score Notification Timing And Transcript Dependency
3 Blood Banking
Products And Components Blood Group Systems And Immunology Serologic And Molecular Testing Compatibility Testing And Transfusion Practice Physiology And Pathophysiology High-Yield Study Strategy
4 Chemistry
Carbohydrates, Lipids, Proteins, And Nitrogen Compounds Enzymes And Heme Derivatives Acid-Base, Blood Gases, And Electrolytes Endocrinology, Vitamins, And Nutrition Therapeutic Drug Monitoring And Toxicology Calculations And Correlation
5 Hematology And Hemostasis
Normal Hematopoiesis And Cell Morphology Anemia And RBC Disorders Leukocyte Disorders And Disease States Platelet And Coagulation Physiology Hemostasis Testing Smear, Analyzer, And Result Correlation
6 Microbiology
Preanalytic Specimen Handling Bacteriology Analytic Procedures Susceptibility And Organism Identification Logic Mycobacteriology, Virology, Parasitology, And Mycology Postanalytic Reporting Safety And Contamination Awareness
7 Urinalysis And Other Body Fluids
Physical And Chemical Urinalysis Microscopic Sediment Renal Physiology And Disease States CSF And Serous Fluids Body Fluid Cell Counts And Crystals Correlation And Preanalytic Issues
8 Immunology
Principles Of Immune Response Immune-System Diseases Infectious Disease Serology Transplantation And Compatibility Concepts Serologic Procedures And Test Methodology Interpretation Pitfalls
9 Laboratory Operations
Quality Assessment And Troubleshooting Safety Laboratory Mathematics Manual And Automated Methodology Instrumentation And Validation Management And Education Principles
10 Integrated Case Reasoning And Calculations
Correlating Patient Results To Disease States Applying Knowledge To New Facts Calculations And Units Procedural Decision-Making QA/QC In Case Questions Avoiding Memorization-Only Study
11 Practice Strategy And Remediation
Content Percentage Allocation CAT-Aware Practice Mindset Reviewing Misses By Domain Using The Official Guideline Before Third-Party Materials Transcript And Result Timing In Planning Final Remediation Cycles
12 Final Review And Exam-Day Readiness
Final-Week Schedule Timing And Pacing Score Expectations Result And Credential Next Steps Digital Badge And Documentation Post-Exam Actions Without Promises
Postanalytic Reporting
Key Takeaways Explain This Topic AI
Critical (panic) results such as positive blood cultures, CSF Gram stains, and AFB smears require immediate notification and documentation.
Preliminary versus final reporting follows the culture timeline: Gram stain first, then ID and susceptibility.
Selective reporting and cascade rules limit which antibiotics are released to guide stewardship.
Reportable communicable diseases trigger public-health notification obligations.
Last updated: November 2026
Turning Verified Results into Safe, Actionable Reports
The postanalytic phase is where microbiology data becomes clinical action, and ASCP tests whether you know what to release, when, and to whom. A core concept is the critical (panic) value -- a result so urgent that CLIA requires the laboratory to alert the requesting clinician immediately; the laboratory's policy sets how the call and read-back are documented.
Microbiology Critical Values
Unlike chemistry numbers, microbiology critical results are qualitative findings that imply life-threatening infection:
A positive blood culture Gram stain (especially gram-positive cocci in clusters or gram-negative rods).
A positive CSF Gram stain or any organism in spinal fluid.
A positive acid-fast (AFB) smear suggesting active tuberculosis (infection-control implications).
Detection of a bioterrorism/select agent (e.g., Bacillus anthracis , Francisella , Brucella ) -- stop work, notify the laboratory director and public health.
A blood/sterile-site positive for a multidrug-resistant organism per facility policy.
Laboratory policy sets the documentation, usually the date/time, the result, the name of the person notified, and read-back confirmation. A stem describing a positive CSF Gram stain that was simply filed in the chart without a call is a postanalytic failure -- the best answer is immediate telephone notification with documentation.
Preliminary vs. Final Reports
Microbiology reporting is sequential because cultures mature over days:
- Stage Typical timing Released
- Preliminary 1 Day 0 (STAT) Gram stain morphology
- Preliminary 2 Day 1 Growth, colony description, presumptive ID
- Final Day 2-3+ Confirmed ID + susceptibilities
A negative culture is also a final report ("no growth after X days"). Anaerobic and mycobacterial cultures need longer hold times before a true negative can be finalized -- finalizing a TB culture at 48 hours is wrong because growth can take weeks.
Selective Reporting and Antimicrobial Stewardship
Laboratories do not report every antibiotic tested. Cascade (selective) reporting releases narrow-spectrum first-line agents and suppresses broad-spectrum drugs unless the first-line drug is resistant. For example, a susceptible E. coli might report ampicillin and cephalexin while a broad carbapenem is suppressed -- this supports stewardship and reduces unnecessary broad-spectrum use. Suppressing drugs to which an organism is intrinsically resistant (e.g., a cephalosporin against Enterococcus ) is also required so clinicians are not misled.
Public-Health Reportable Diseases
Certain organisms trigger mandatory notification to state/local public health regardless of the ordering clinician's wishes. High-yield reportable findings include Mycobacterium tuberculosis , Neisseria meningitidis , Salmonella / Shigella , Vibrio cholerae , Neisseria gonorrhoeae , and any suspected select agent. The MLS role is to flag the result through the laboratory's reporting workflow; failing to report a reportable communicable disease is both a quality and a legal lapse.
When a postanalytic item appears, identify whether it is a critical value, a stewardship/reporting rule, or a public-health duty, then choose the action the stem actually requires.
Result Verification, Correlation, and Error Correction
Before any microbiology result is released, the technologist performs result verification -- confirming the identification and susceptibility are internally consistent and biologically plausible. The exam tests "delta" and correlation checks adapted to microbiology: a susceptibility profile that contradicts the organism's known intrinsic resistance must be flagged before reporting. For example, an Enterococcus reported as cephalosporin-susceptible, or a Stenotrophomonas reported as carbapenem-susceptible, signals a setup or identification error, not a real finding.
Catching the contradiction is the best answer over simply releasing the panel.
Gram Stain and Culture Correlation
Gram stain results should correlate with culture growth. If the direct Gram stain of a wound showed abundant gram-positive cocci in clusters but the culture grew only gram-negative rods, the discrepancy must be investigated -- possible causes include a missed fastidious or anaerobic organism, antibiotic suppression of the cluster organism, or a labeling/processing error. The exam expects the technologist to reconcile the smear with the plate rather than ignore one of them.
Reporting Format and Amended Reports
Proper reporting language matters and is testable:
Report quantity when clinically meaningful (e.g., urine colony counts as CFU/mL; light/moderate/heavy growth).
Use approved nomenclature and avoid ambiguous abbreviations.
A negative culture is reported as "no growth after [X] days" with the appropriate incubation period for the organism class.
An amended/corrected report must be issued when an error is found after release, with the original result retained for the audit trail -- you never silently overwrite a released result.
Turnaround Time and Stewardship Linkage
Faster accurate reporting changes therapy, so the exam connects postanalytic speed to outcomes. A preliminary Gram stain reported within an hour lets clinicians start empiric therapy; a rapid molecular blood-culture panel that reports organism and key resistance genes within hours shortens time to optimal therapy and is a major stewardship lever. A worked scenario: a blood culture flags positive at 2 a.m., the Gram stain shows gram-positive cocci in clusters, and a rapid mecA result is positive.
The correct postanalytic actions are an immediate critical-value call, a preliminary report of presumptive MRSA, and documentation -- not waiting until the morning shift to release anything. Tie every postanalytic item to one question: does this result need to be verified, correlated, corrected, or urgently communicated , and to whom? Answer that, and the best option becomes clear, because microbiology reporting is judged by whether the right person can act on the result in time.